Heart diseases summit 2020

Posts

4 Reasons Not to Miss ‘Advances in Pediatric and Congenital Heart Summit’

For the third year running, world experts in congenital heart disease will gather at Cleveland’s InterContinental Hotel & Conference Center in late September to share clinical insights at Cleveland Clinic’s Advances in Pediatric and Congenital Heart Summit . This year’s CME-certified event, subtitled “Atrial Isomerism — the Road to Survival,” runs from Thursday morning, Sept. 27, through midday Saturday, Sept. 29. The first day promises benefits for clinicians looking for a general update on congenital heart disease, while the final day and a half is tailored to those desiring an in-depth exploration of the rare defect known as atrial isomerism (heterotaxy syndrome). The overall program offers at least four reasons pediatric and adult cardiologists or cardiac surgeons with an interest in congenital heart disease should consider this a must-attend event. 1) One of the deepest dives ever into atrial isomerism How misaligned cardiac embryological development leads to cardiac

Data Science about Heart Failure

Click the link for info https://towardsdatascience.com/heart-disease-prediction-73468d630cfc About 610,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths .1 Heart disease is the leading cause of death for both men and women. More than half of the deaths due to heart disease in 2009 were in men.1 Coronary Heart Disease(CHD) is the most common type of heart disease, killing over 370,000 people annually. Every year about 735,000 Americans have a heart attack. Of these, 525,000 are a first heart attack and 210,000 happen in people who have already had a heart attack.

Heart Diseases Summit 2020

The Summit with the World class Cardiologists .. i am so excited, the abstracts received until now are the best research work in the filed of Cardiology the titles of the abstract are Title : Cor Triatriatum Sinister and Patent Ductus Arteriosus in a 23 year-old Filipina Title : Behavior of QT interval in HIV-Infected Patients Receiving Antiretroviral Therapy. Title : Factors associated with development of hospital acquired infection in the tertiary level neonatal intensive care unit. Title : Our First Experience in Stenting of Coarctation of Aorta in Infants and Small Children (less than 10 Kg) Title : Fibrinogen relation to outcomes in congenital heart surgery Title : How do doctors calculate medication doses in childhood obesity? A retrospective evaluation of prescriptions in paediatric patients in Casey Hosptial, Melbourne Title : Posterior reversible encephalopathy in a child with anemia and hypertension Title : Emergency Neonatal Surgery: Outcome in a

Classification of Cardiovascular Drugs

Classification of Cardiovascular Drugs The hashtag # Cardiovascular_Drugs Cardiovascular agents are medicines that are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. Discuss on Various Classification of Cardiovascular Drugs and their Novel Developments at the Heart Diseases Summit 2020 on april 20-21,2020 Discussion on various topics on Heart Diseases Carried out at https://heartdiseases.conferenceseries.com/asiapacific/ For more details Contact Samanta Grace Program Manager heartdiseases@asiameets.com website : https://heartdiseases.conferenceseries.com/asiapacific/ hashtag # cardiovascular hashtag # cardiovascular hashtag # cardiology hashtag # diabetes hashtag # cancer hashtag # cardiovascular_disease hashtag # heart_disease hashtag # heart_diseases hashtag #